Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2021-05-21 Regulatory Filings
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about a scheduled Board Meeting to consider approval of unaudited and audited financial results for the quarter and year ended March 31, 2021, and recommendation of dividend. It is an intimation of a future event (Board Meeting) and not the actual financial results or report itself. The document is short (2125 characters) and serves as a notification rather than containing substantive financial data or analysis. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about a Board Meeting and upcoming financial results, not the results themselves or a detailed report.
2021-05-21 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the receipt of ANDA approval from the USFDA for a pharmaceutical product by Unichem Laboratories Limited. It is addressed to stock exchanges under SEBI regulations and contains no financial statements, detailed financial analysis, or management discussion. The document length is 3610 characters, which is relatively short and typical for a regulatory announcement or press release. It does not contain any financial report or detailed investor presentation content. It is an update on a regulatory approval event, which is a typical regulatory filing or announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit into other specific categories like Annual Report, Earnings Release, or Capital Update.
2021-05-20 English
Press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem's Amitriptyline HCl Tablets USP.
Regulatory Filings Classification · 95% confidence The document is a press release announcing the receipt of ANDA approval from the USFDA for a pharmaceutical product by Unichem Laboratories Limited. It is addressed to stock exchanges under SEBI regulations and contains no financial statements, detailed financial data, or management discussion. The document length is 3610 characters, which is relatively short and typical for a press release or regulatory announcement. It does not contain an annual report, earnings release, or any detailed financial or governance information. The content is an update on a regulatory approval event, which is a typical regulatory filing or announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit into more specific categories like earnings, annual reports, or management changes.
2021-05-20 English
Advertisement Published in Newspapers regarding Notice for transfer of Equity Shares and Unclaimed Dividend to the Investor Education and Protection Fund (IEPF) Account.
Regulatory Filings
2021-05-19 English
Copy of Newspaper Publication
Regulatory Filings
2021-05-19 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding compliance with Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the issuance of a duplicate share certificate due to loss or misplacement of the original certificate. The content focuses on share certificate replacement and does not contain financial data, earnings, management discussion, or other report types. It is a regulatory announcement related to shareholding documentation but not a major shareholding notification or share issue. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-05-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.